Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 1,501 - 1,525 of 2,711

«
1
…
59
60
61
62
63
…
109
»

Updates in Treatment of Early Stage and Locally Advanced NSCLC

Updates in Treatment of Early Stage and Locally Advanced NSCLC

By: Erminia Massarelli, MD, PhD, MS

Updates in Treatment of Early Stage and Locally Advanced NSCLC

Updates in Treatment of Early Stage and Locally Advanced NSCLC

By: Erminia Massarelli, MD, PhD, MS

Updates in Treatment of Early Stage and Locally Advanced NSCLC

Updates in Treatment of Early Stage and Locally Advanced NSCLC

By: Erminia Massarelli, MD, PhD, MS

Updates in Treatment of Early Stage and Locally Advanced NSCLC

Updates in Treatment of Early Stage and Locally Advanced NSCLC

By: Erminia Massarelli, MD, PhD, MS

KRAS and EGFR Exon 20 Insertion

KRAS and EGFR Exon 20 Insertion

By: Erminia Massarelli, MD, PhD, MS

Other Driver Mutations: ROS-1, BRAF, MET and RET

Other Driver Mutations: ROS-1, BRAF, MET and RET

By: Erminia Massarelli, MD, PhD, MS

Updates in Immunotherapy for Metastatic Lung Cancer

Updates in Immunotherapy for Metastatic Lung Cancer

By: Erminia Massarelli, MD, PhD, MS

Other Driver Mutations: ROS-1, BRAF, MET and RET

Other Driver Mutations: ROS-1, BRAF, MET and RET

By: Erminia Massarelli, MD, PhD, MS

ERBB2 and NGR1 Pathways in NSCLC

ERBB2 and NGR1 Pathways in NSCLC

By: Estelamari Rodriguez, MD

ERBB2 and NGR1 Pathways in NSCLC

ERBB2 and NGR1 Pathways in NSCLC

By: Estelamari Rodriguez, MD

The Role of Co-Mutations with Immunotherapy Response in NSCLC

The Role of Co-Mutations with Immunotherapy Response in NSCLC

By: Ferdinando Skoulidis, MD

The Role of Co-Mutations with Immunotherapy Response in NSCLC

The Role of Co-Mutations with Immunotherapy Response in NSCLC

By: Ferdinando Skoulidis, MD

Pan-KRAS Inhibitors: Where are We Going?

Pan-KRAS Inhibitors: Where are We Going?

By: Ferdinandos Skoulidis, MD

Pan-KRAS Inhibitors: Where are We Going?

Pan-KRAS Inhibitors: Where are We Going?

By: Ferdinandos Skoulidis, MD

Pre-Operative and Metastatic Setting Biomarkers for Immunotherapy in Lung Cancer

Pre-Operative and Metastatic Setting Biomarkers for Immunotherapy in Lung Cancer

By: Fred Hirsch, MD

Pre-Operative and Metastatic Setting Biomarkers for Immunotherapy in Lung Cancer

Pre-Operative and Metastatic Setting Biomarkers for Immunotherapy in Lung Cancer

By: Fred Hirsch, MD

SCLC & Squamous NSCLC: New Standards

SCLC & Squamous NSCLC: New Standards

By: Genelis Domingo, MD

How to Choose Front Line Therapy for Metastatic Non-Driver Mutation NSCLC

How to Choose Front Line Therapy for Metastatic Non-Driver Mutation NSCLC

By: George R. Simon, MD, FACP, FCCP

How to Choose Front Line Therapy for Metastatic Non-Driver Mutation NSCLC

How to Choose Front Line Therapy for Metastatic Non-Driver Mutation NSCLC

By: George R. Simon, MD, FACP, FCCP

Immunotherapy in Advanced NSCLC: Initial Therapy and How to Overcome Resistance

Immunotherapy in Advanced NSCLC: Initial Therapy and How to Overcome Resistance

By: George Simon, MD, FACP, FCCP

Immunotherapy in Advanced NSCLC: Initial Therapy and How to Overcome Resistance

Immunotherapy in Advanced NSCLC: Initial Therapy and How to Overcome Resistance

By: George Simon, MD, FACP, FCCP

Small cell and Squamous Cell Lung Cancer

Small cell and Squamous Cell Lung Cancer

By: Goetz Kloecker, MD MSPH MBA

Small cell and Squamous Cell Lung Cancer Update

Small cell and Squamous Cell Lung Cancer Update

By: Goetz Kloecker, MD MSPH MBA FACP

Metastatic Targeted Therapy Updates

Metastatic Targeted Therapy Updates

By: Goetz Kloecker, MD, MSPH, MBA, FACP

Metastatic Targeted Therapy Updates

Metastatic Targeted Therapy Updates

By: Goetz Kloecker, MD, MSPH, MBA, FACP

«
1
…
59
60
61
62
63
…
109
»

Post navigation

← Previous View

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok